Barbara Gripshover

1.7k total citations
48 papers, 1.2k citations indexed

About

Barbara Gripshover is a scholar working on Infectious Diseases, Emergency Medicine and Epidemiology. According to data from OpenAlex, Barbara Gripshover has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 17 papers in Emergency Medicine and 16 papers in Epidemiology. Recurrent topics in Barbara Gripshover's work include HIV/AIDS Research and Interventions (20 papers), HIV-related health complications and treatments (17 papers) and HIV Research and Treatment (15 papers). Barbara Gripshover is often cited by papers focused on HIV/AIDS Research and Interventions (20 papers), HIV-related health complications and treatments (17 papers) and HIV Research and Treatment (15 papers). Barbara Gripshover collaborates with scholars based in United States, Greece and New Zealand. Barbara Gripshover's co-authors include Robert A. Salata, Michael M. Lederman, Grace A. McComsey, Robert Asaad, Robert C. Kalayjian, Ian Woolley, D. James Morré, Gene D. Morse, Michelle V. Lisgaris and Benigno Rodríguez and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLANT PHYSIOLOGY.

In The Last Decade

Barbara Gripshover

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Gripshover United States 15 809 627 413 293 135 48 1.2k
Hans-Jürgen Stellbrink Germany 10 1.4k 1.7× 1.1k 1.7× 584 1.4× 257 0.9× 106 0.8× 12 1.7k
Tiziana Quirino Italy 22 841 1.0× 493 0.8× 557 1.3× 331 1.1× 54 0.4× 60 1.5k
J. Durant France 21 1.3k 1.6× 1.1k 1.8× 250 0.6× 380 1.3× 88 0.7× 91 1.9k
Stephen Becker United States 18 654 0.8× 440 0.7× 164 0.4× 199 0.7× 169 1.3× 33 974
Reena Rajasuriar Malaysia 22 449 0.6× 609 1.0× 352 0.9× 368 1.3× 404 3.0× 66 1.4k
Jonathan Ainsworth United Kingdom 18 792 1.0× 515 0.8× 236 0.6× 492 1.7× 68 0.5× 44 1.2k
Rachael Jones United Kingdom 20 816 1.0× 279 0.4× 464 1.1× 240 0.8× 14 0.1× 65 1.2k
Pierre de Truchis France 19 653 0.8× 582 0.9× 463 1.1× 276 0.9× 98 0.7× 42 1.1k
Yang Han China 23 1.2k 1.5× 487 0.8× 273 0.7× 376 1.3× 180 1.3× 104 1.8k
F Mulcahy Ireland 19 800 1.0× 316 0.5× 159 0.4× 594 2.0× 38 0.3× 66 1.4k

Countries citing papers authored by Barbara Gripshover

Since Specialization
Citations

This map shows the geographic impact of Barbara Gripshover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Gripshover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Gripshover more than expected).

Fields of papers citing papers by Barbara Gripshover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Gripshover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Gripshover. The network helps show where Barbara Gripshover may publish in the future.

Co-authorship network of co-authors of Barbara Gripshover

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Gripshover. A scholar is included among the top collaborators of Barbara Gripshover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Gripshover. Barbara Gripshover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Longenecker, Christopher T., Kelley A. Jones, Corrilynn O. Hileman, et al.. (2024). Nurse-Led Strategy to Improve Blood Pressure and Cholesterol Level Among People With HIV. JAMA Network Open. 7(3). e2356445–e2356445. 5 indexed citations
2.
Wu, Hulin, Thomas P. Giordano, Maile Karris, et al.. (2024). A New Approach to Discovering HIV Symptom and Patient Clusters Using CNICS Data and Topic Modeling. 1–8. 1 indexed citations
3.
Patil, Nirav, Barbara Gripshover, Christopher Hammond, et al.. (2023). Evaluation of an emergency department opt-out provider-driven HIV and syphilis screening and linkage-to-care program. The American Journal of Emergency Medicine. 77. 187–193. 3 indexed citations
4.
Willig, Amanda L., Thomas W. Buford, Prema Menezes, et al.. (2023). Brief Report: Relationship Between Adiposity and Biomarkers of Aging and Frailty Among Adults Aging With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 95(4). 377–382. 1 indexed citations
5.
Luque, Amneris E., Barry S. Zingman, Margaret A. Fischl, et al.. (2016). Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. Current Vascular Pharmacology. 14(3). 280–287. 8 indexed citations
6.
Hileman, Corrilynn O., et al.. (2013). Effects of HIV and Antiretroviral Therapy on Resting Energy Expenditure in Adult HIV-Infected Women—A Matched, Prospective, Cross-Sectional Study. Journal of the Academy of Nutrition and Dietetics. 113(8). 1037–1043. 13 indexed citations
7.
Taiwo, Babafemi, Peter W. Hunt, Rajesh T. Gandhi, et al.. (2013). CD8+ T-Cell Activation in HIV-1–Infected Patients Experiencing Transient Low-level Viremia During Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1). 101–104. 25 indexed citations
8.
Slomka, Jacquelyn, et al.. (2012). How Have Long-Term Survivors Coped With Living With HIV?. Journal of the Association of Nurses in AIDS Care. 24(5). 449–459. 26 indexed citations
9.
Ma, Qing, Barry S. Zingman, Amneris E. Luque, et al.. (2011). Therapeutic Drug Monitoring of Protease Inhibitors and Efavirenz in HIV-Infected Individuals With Active Substance-Related Disorders. Therapeutic Drug Monitoring. 33(3). 309–314. 3 indexed citations
10.
Hileman, Corrilynn O., Teresa L. Carman, Barbara Gripshover, et al.. (2010). Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults. AIDS. 24(12). 1958–1961. 13 indexed citations
11.
Tien, Phyllis C., Donald P. Kotler, Edgar T. Overton, et al.. (2008). Regional Adipose Tissue and Elevations in Serum Aminotransferases in HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(2). 169–176. 7 indexed citations
12.
Ma, Qing, Barry S. Zingman, Richard C. Reichman, et al.. (2007). Assessing the Impact of Substance use and Hepatitis Coinfection on Atazanavir and Lopinavir Trough Concentrations in HIV-Infected Patients During Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 29(5). 560–565. 13 indexed citations
13.
DiFrancesco, Robin, Margaret A. Fischl, Barry S. Zingman, et al.. (2007). Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users. Journal of Pharmaceutical and Biomedical Analysis. 44(1). 188–195. 4 indexed citations
14.
Tien, Phyllis C., et al.. (2007). Association Between Hepatitis C Virus Coinfection and Regional Adipose Tissue Volume in HIV-Infected Men and Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(1). 60–65. 9 indexed citations
15.
DiFrancesco, Robin, Barry S. Zingman, Richard C. Reichman, et al.. (2007). Integration of Atazanavir into an Existing Liquid Chromatography UV Method for Protease Inhibitors: Validation and Application. Therapeutic Drug Monitoring. 29(1). 103–109. 19 indexed citations
16.
McComsey, Grace A., et al.. (2003). Effect of Antioxidants on Glucose Metabolism and Plasma Lipids in HIV-Infected Subjects With Lipoatrophy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(5). 605–607. 15 indexed citations
17.
Asaad, Robert, Ian Woolley, R. Davidson, et al.. (2001). Changing Spectrum of Mortality Due to Human Immunodeficiency Virus: Analysis of 260 Deaths during 1995-1999. Clinical Infectious Diseases. 32(10). 1487–1493. 123 indexed citations
18.
Lederman, Michael M., et al.. (1999). Human Immunodeficiency Virus 1 Protease Inhibitors in Clinical Practice. Archives of Internal Medicine. 159(15). 1771–1771. 73 indexed citations
19.
Smith, Michael C., John T. Carey, Steven N. Emancipator, et al.. (1996). Prednisone Improves Renal Function and Proteinuria in Human Immunodeficiency Virus-associated Nephropathy. The American Journal of Medicine. 101(1). 41–48. 96 indexed citations
20.
Gripshover, Barbara, D. James Morré, & Wendy F. Boss. (1984). Fractionation of suspension cultures of wild carrot and kinetics of membrane labeling. PROTOPLASMA. 123(3). 213–220. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans-Jürgen Stellbrink Breakdown of academic impact, for papers by Tiziana Quirino Breakdown of academic impact, for papers by J. Durant Breakdown of academic impact, for papers by Stephen Becker Breakdown of academic impact, for papers by Reena Rajasuriar Breakdown of academic impact, for papers by Jonathan Ainsworth Breakdown of academic impact, for papers by Rachael Jones Breakdown of academic impact, for papers by Pierre de Truchis Breakdown of academic impact, for papers by Yang Han Breakdown of academic impact, for papers by F Mulcahy
Rankless by CCL
2026